CURE’s neuroendocrine cancer page features the latest cancer news and updates on neuroendocrine cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in neuroendocrine cancer.
April 14th 2025
The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors.